Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EU Extends Pilot On Splitting Mutual Recognition/Decentralized Procedures

Executive Summary

Drug companies in the EU are getting more time to experiment with splitting their mutual recognition and decentralized procedure licences to help with their marketing strategies.


Related Content

Pharma Taken By EU Pilot On Merging MRP/DCP Lines
EU To Test Merging & Splitting Of Licences Under Mutual Recognition/Decentralized Procedures